An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020610
Company: VALEANT PHARMS INTL

Products on NDA 020610

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
COLAZAL	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 020610

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/18/2000	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20610lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20610ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-610_Colazal.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/24/2023	SUPPL-26	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020610s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/020610Orig1s026ltr.pdf
11/16/2022	SUPPL-25	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020610s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020610Orig1s025ltr.pdf
11/01/2021	SUPPL-24	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020610s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020610Orig1s024ltr.pdf
10/01/2020	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020610s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020610Orig1s023ltr.pdf
06/21/2019	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020610s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020610Orig1s021ltredt.pdf
01/05/2015	SUPPL-20	Manufacturing (CMC)		Label is not available on this site.
03/05/2014	SUPPL-19	Manufacturing (CMC)		Label is not available on this site.
07/09/2008	SUPPL-18	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020610s018ltr.pdf
11/02/2007	SUPPL-17	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020610s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020610s017ltr.pdf
12/20/2006	SUPPL-16	Efficacy-New Patient Population	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020610s016ltr.pdf
09/21/2006	SUPPL-14	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020610s014ltr.pdf
03/10/2006	SUPPL-13	Manufacturing (CMC)-Packaging	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020610s013ltr.pdf
02/07/2002	SUPPL-2	Manufacturing (CMC)		Label is not available on this site.
06/18/2002	SUPPL-1	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20610s001ltr.pdf

Labels for NDA 020610

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/24/2023	SUPPL-26	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020610s026lbl.pdf
11/16/2022	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020610s025lbl.pdf
11/01/2021	SUPPL-24	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020610s024lbl.pdf
10/01/2020	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020610s023lbl.pdf
06/21/2019	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020610s021lbl.pdf
11/02/2007	SUPPL-17	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020610s017lbl.pdf
12/20/2006	SUPPL-16	Efficacy-New Patient Population	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s016lbl.pdf
09/21/2006	SUPPL-14	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s014lbl.pdf
07/18/2000	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20610lbl.pdf

Therapeutic Equivalents for NDA 020610

COLAZAL

CAPSULE;ORAL; 750MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BALSALAZIDE DISODIUM	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	No	AB	077883	APOTEX
BALSALAZIDE DISODIUM	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	No	AB	219422	CARNEGIE
BALSALAZIDE DISODIUM	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	No	AB	077806	HIKMA
BALSALAZIDE DISODIUM	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	No	AB	077807	NOVITIUM PHARMA
BALSALAZIDE DISODIUM	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	No	AB	217592	ZYDUS LIFESCIENCES
COLAZAL	BALSALAZIDE DISODIUM	750MG	CAPSULE;ORAL	Prescription	Yes	AB	020610	VALEANT PHARMS INTL

Top